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Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci were detected at low frequencies (o20%) among 69
pulmonary mucosa-associated lymphoid tissue (MALT) lymphomas, 30 other lymphoproliferative disorders (LPD) and 44 non-LPD.
The incidence of individual Chlamydiae was generally higher in MALT lymphoma than non-LPD, although not reaching statistical
significance. Mycoplasma pneumoniae DNA was not detected.
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Mucosa-associated lymphoid tissue (MALT) lymphoma arises
from the MALT acquired as a result of chronic inflammatory or
autoimmune disorder (Isaacson and Du, 2004). The inflammatory
process and the accompanying immunological responses provide a
microenvironment essential for malignant transformation and for
the subsequent expansion of the transformed clone. This is best
exemplified in gastric MALT lymphoma, which is caused by
chronic Helicobacter pylori infection and can be effectively treated
by eradication of the organism with antibiotics (Wotherspoon
et al, 1993). Growing evidence indicates that the development of
non-gastric MALT lymphoma is also associated with infection by
microbial pathogens. Borrelia burgdorferi and Campylobacter
jejuni are associated with cutaneous marginal zone B-cell
lymphoma and immunoproliferative small intestinal disease,
respectively (Cerroni et al, 1997; Lecuit et al, 2004). Recent studies
show that Chlamydia psittaci is variably associated with ocular
adnexal MALT lymphoma in different geographical regions
(Ferreri et al, 2004; Chanudet et al, 2006) and eradication of the
organism results in complete regression of the lymphoma in some
cases (Ferreri et al, 2005).
The aetiological factors underlying the development of pulmon-
ary MALT lymphoma are unknown. Nonetheless, Chlamydia sp.
and Mycoplasma pneumoniae can cause chronic pulmonary
diseases such as chronic bronchitis and adult-onset asthma
(Bjornsson et al, 1996; Daian et al, 2000), and chronic infection
with C. pneumoniae or M. pneumoniae has been linked to an
increased risk of lung cancer (Pehlivan et al, 2004; Littman et al,
2005). C. pneumoniae and C. trachomatis infections, particularly
the former, are also associated with an increased risk of lymphoma
although their specific association with pulmonary MALT
lymphoma is unclear (Anttila et al, 1998). The present study was
thus designed to examine the potential association of Chlamydiae
and Mycoplasma infection with pulmonary MALT lymphoma.
MATERIALS AND METHODS
Archival formalin-fixed paraffin-embedded lung biopsies (mainly
parenchymal biopsies, occasionally biopsies of the bronchial
mucosa) of 159 patients from 3 geographical areas, obtained
between 1983 and 2006, were analysed. In all cases, the lung was
the primary site of the disease. Local ethical guidelines were
followed for the use of archival paraffin-embedded tissues for
research and such use was approved by the local ethics committees
of the author’s institutions.
DNA was purified from whole tissue sections, and checked for
integrity by multiplex PCR amplification of variously sized human
gene fragments (100, 200, 300 and 400bp) (Chanudet et al, 2006).
Of the 159 cases, 143 had adequate materials as judged by quality
control PCR and were thus suitable for PCR-based screening of
microbial pathogens. These included 69 primary pulmonary MALT
lymphomas, 30 pulmonary cases with other lymphoproliferative
disorders (other-LPD), and 44 lung biopsies without any
histological evidence of an LPD (non-LPD) (Table 1).
The detection of C. psittaci, C. pneumoniae and C. trachomatis
was carried out separately using a previously described Touch-
down PCR (Chanudet et al, 2006). Mycoplasma pneumoniae was
detected by PCR of the Mycoplasma-associated P1 adhesion
protein gene as described previously (Hardegger et al, 2000).
Stringent laboratory procedures for PCR set-up and product
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sanalysis were carefully followed to avoid any potential cross-
contamination. PCR products were analysed by electrophoresis on
10% polyacrylamide gels. Positive PCR products were purified and
sequenced using an ABI 377 DNA sequencer (ABI PRISM Perkin
Elmer) to confirm the specificity of PCR. In each case, three
independent PCRs were carried out for each microbial species and
only cases with positive PCR results in at least two of the three
independent reactions were regarded as positive (Ferreri et al,
2004; Chanudet et al, 2006).
Differences in the prevalence of infectious agents among various
lymphoma subtypes and controls were analysed using Fisher’s
exact test (‘stats Package’ in R version 2.1.1).
t(11;18)(q21;q21) and t(1;14)(p22;q32) were screened in 33 cases
of MALT lymphoma by interphase fluorescence in situ hybridisa-
tion in previous investigations (Ye et al, 2003).
RESULTS
Of the 143 cases screened for the presence of Chlamydia and
Mycoplasma (Figure 1), quality control PCR did not show any
differences in the quality of DNA samples from MALT lymphoma
or control groups, or from different geographical regions.
Sequencing of PCR products confirmed specific amplification of
all PCR primer sets.
Overall, 24 of 69 (35%) MALT lymphomas were positive for at
least one of the three Chlamydia species, a frequency significantly
higher than that in non-LPD (18%, P¼0.043) but not other-LPD
(27%, P¼0.29). With the exception of two cases of MALT
lymphoma (one from Italy and the other from UK), the presence
of three Chlamydia species was mutually exclusive.
When the prevalence of individual Chlamydia species in various
groups was examined within the same geographical region, no
significant difference in the prevalence of each Chlamydia species
was found between MALT lymphoma and other- or non-LPD
group in all the three regions examined (Table 2). Nonetheless, the
prevalence of C. trachomatis in MALT lymphoma (19%) was
higher than those in other-LPD (5%) and non-LPD (4%) in
Germany. Chlamydia pneumoniae was also detected more
frequently in MALT lymphoma (23%) than other-LPD group
(10%) in Italy. Chlamydia psittaci was found at low frequencies in
MALT lymphoma, but absent in control groups in all three
geographical regions. There was no correlation between Chlamydia
positivity and age or sex of the patients. There was also no
correlation between Chlamydia positivity and presence of
t(11;18)(q21;q21) and t(1;14)(p22;q32) in 33 cases of MALT
lymphoma from the United Kingdom and Germany, in which the
translocation status was available from previous investigations.
Remarkably, the four cases of DLBCL positive for a Chlamydia
infection (three with C. pneumoniae and one with C. trachomatis)
were all de novo. Mycoplasma pneumoniae was not detected in any
MALT lymphoma and control cases despite the high sensitivity of
Table 1 Demographic and histological characteristics of pulmonary
MALT lymphomas and controls from different geographical areas
Diagnosis UK
a Germany
b Italy
c
No. of patients
MALT L 35 21 13
Other-LPD — 20 10
Non-LPD 20 24 —
Median age (range)
MALT L 56 (37–78) 59 (35–78) 60 (35–84)
Other-LPD — 59 (16–84) 53 (31–77)
Non-LPD 48 (14–66) 60 (24–75) —
Male/female ratio
MALT L 1.1 1.3 1.2
Other-LPD — 1.2 0.4
Non-LPD 1 2.4 —
LPD¼lymphoproliferative disorder; MALT L¼mucosa-associated lymphoid tissue
lymphoma.
aA total of 34 cases of MALT lymphoma from London and one case of
MALT lymphoma from Cambridge. Control group includes 20 cases of non-
lymphoproliferative disorders (mostly pneumonia and bronchiectasis) from London.
bAll cases from Wu ¨rzburg. Control groups consists of 20 cases of lymphoproliferative
disorders other than MALT lymphoma (nine diffuse large B-cell lymphomas, three
Hodgkin’s lymphomas, two lymphomatoid granulomatosis, three mediastinal/
anaplastic large cell lymphomas, one plasmocytoma, one mantle cell lymphoma and
one NK-cell lymphoma) and 24 cases of non-lymphoproliferative disorders (mainly
carcinomas).
cA total of nine cases of MALT lymphoma from Ancona and the
remaining four cases from Bologna. Control group includes 10 cases of
lymphoproliferative disorders other than MALT lymphoma (five diffuse large B-cell
lymphomas, two follicular bronchiolitis, one mantle cell lymphoma, one Hodgkin’s
lymphoma and one lymphoplasmacytic lymphoma).
M + S1 S2 S3 S4 S5 –
100 bp
100 bp
100 bp
150 bp
125 bp
125 bp
75 bp (73 bp)
C. pneumoniae
(116 bp)
C. trachomatis
(111 bp)
C. psittaci
Figure 1 PCR detection of Chlamydia pneumoniae, Chlamydia tracho-
matis and Chlamydia psittaci DNA in pulmonary mucosa-associated
lymphoid tissue (MALT) lymphoma specimen (10% polyacrylamide gel).
M¼molecular weight marker; þ¼positive control;  ¼negative control;
S1–S5¼different MALT lymphomas; S2¼positive for both C. pneumoniae
and C. trachomatis.
Table 2 Frequencies of Chlamydiae and mycoplasma detected in
pulmonary lymphomas and controls from different geographical areas
a
Diagnosis UK Germany Italy Total
Chlamydia pneumoniae
MALT L 2/35 6% 3/21 14% 3/13 23% 8/69 12%
Other-LPD — — 4/20 20% 1/10 10% 5/30 17%
Non-LPD 1/20 5% 2/24 8% — — 3/44 7%
Chlamydia trachomatis
MALT L 8/35 23% 4/21 19% 2/13 15% 14/69 20%
Other-LPD — — 1/20 5% 2/10 20% 3/30 10%
Non-LPD 4/20 20% 1/24 4% — — 5/44 11%
Chlamydia psittaci
MALT L 2/35 6% 1/21 5% 1/13 8% 4/69 6%
Other-LPD — — 0/20 0% 0/10 0% 0/30 0%
Non-LPD 0/20 0% 0/24 0% — — 0/44 0%
Mycoplasma pneumoniae
MALT L 0/35 0% 0/21 0% 0/13 0% 0/69 0%
Other-LPD — — 0/20 0% 0/10 0% 0/30 0%
Non-LPD 0/20 0% 0/24 0% — — 0/44 0%
LPD¼lymphoproliferative disorder; MALT L¼mucosa-associated lymphoid tissue
lymphoma.
aA case was regarded as positive if the screened bacterium was detected
in at least two of three independent PCRs (Chanudet et al, 2006).
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sthe PCR, which was capable of detecting as few as three copies of
M. pneumoniae genome.
DISCUSSION
To our knowledge, this is the first study investigating the presence
of infectious agents in pulmonary MALT lymphoma. Our results
show low frequencies of C. pneumoniae, C. trachomatis and C.
psittaci infection in pulmonary MALT lymphomas. The prevalence
of the individual Chlamydiae was in general higher in pulmonary
MALT lymphoma than non-LPD group. Nonetheless, this is not
statistically significant; larger series of both MALT lymphomas and
appropriate controls are required to assess the possible association
of Chlamydia infection with pulmonary MALT lymphoma.
The low frequencies of Chlamydiae infection observed in
pulmonary MALT lymphoma are analogous to the low prevalence
of B. burgdorferi in cutaneous marginal zone B-cell lymphoma and
C. psittaci in ocular adnexal MALT lymphoma (Cerroni et al, 1997;
Chanudet et al, 2006). Together, these observations highlight an
important issue for the study of microbial pathogens associated
with non-gastric MALT lymphomas. The microbial pathogens
associated with MALT lymphoma may reflect the spectrum of
infectious agents that are capable of colonising and causing
chronic infections at the respective mucosal sites. Unlike stomach
where only H. pylori and its related species can survive the hostile
acidic environment, lung is susceptible to a wide range of
infectious agents. While gastric MALT lymphomas are invariably
associated with Helicobacter species, pulmonary MALT lymphoma,
similarly to other non-gastric MALT lymphomas, might be
associated with several infectious agents. A recent study from
Italy showed that 6 of the 13 C. psittaci negative ocular MALT
lymphomas also responded to antibiotic treatment, suggesting the
presence of other bacteria (Ferreri et al, 2006).
Remarkably, all cases tested in this study were negative for
M. pneumoniae despite the high sensitivity of the PCR detection. This,
together with the absence of Chlamydia infection in the majority of
pulmonary MALT lymphomas, suggests the presence of other
aetiological factors in the development of this lymphoma.
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